Skip to main content
logo
Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.605
-0.055 (-1.50%)
At close: Aug 26, 2026, 4:00 PM EDT
3.560
-0.045 (-1.25%)
Pre-market: Aug 27, 2026, 5:13 AM EDT

Anixa Biosciences Ratios and Metrics

Millions USD. Fiscal year is Nov - Oct.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Market Capitalization
12313611398172143
Market Cap Growth
24.39%20.70%14.71%-42.82%20.19%191.52%
Enterprise Value
1091199172139106
Last Close Price
3.604.133.503.165.604.77

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Forward PE
-4.854.854.854.274.27
PS Ratio
---467.53-279.02
PB Ratio
8.459.745.964.206.094.11
P/TBV Ratio
8.478.975.634.035.914.03

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
EV/Sales Ratio
---342.38-206.32

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Debt / Equity Ratio
0.010.020.010.010.010.01
Net Debt / Equity Ratio
-1.02-1.07-1.04-1.01-1.04-1.02
Net Debt / EBITDA Ratio
-----2.71
Net Debt / FCF Ratio
1.902.092.693.814.547.18
Asset Turnover
---0.01-0.02
Quick Ratio
9.157.718.0411.8914.6028.13
Current Ratio
9.798.088.5512.5014.8328.35
Return on Equity (ROE)
-71.97%-67.17%-60.10%-38.51%-43.74%-61.02%
Return on Assets (ROA)
-41.91%-38.83%-36.70%-24.61%-26.02%-35.92%
Return on Capital Employed (ROCE)
-79.90%-82.90%-72.40%-46.90%-48.90%-37.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Earnings Yield
-8.18%-8.04%-11.15%-9.99%-7.92%-9.07%
FCF Yield
-5.80%-5.28%-6.51%-6.32%-3.78%-3.46%
Buyback Yield / Dilution
-2.80%-1.74%-2.96%-1.99%-6.28%-28.57%
SEC Filings: 10-K · 10-Q